Status: Recruiting
A Study of Lebrikizumab in Adults With Nummular Eczema
The main aim of the study is to evaluate the efficacy, safety, and tolerability of lebrikizumab treatment in adult participants with Nummular Eczema (NE) who are not adequately controlled with Topical corticosteroids (TCS) or when this treatment is not medically advisable.
Participants needed: 270
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Almirall, S.A.Updated: Aug 17, 2026Locations: 1
Eligibility criteria
Ability to understand the purpose and risks of the trial, willingness and abilit... [+4]
Documented history or current presence of moderate-to-severe AD at the Screening... [+20]